Variant report
Variant | nsv1018561 |
---|---|
Chromosome Location | chr9:21181454-21228248 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:630)
- CpG islands (count:122)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr9:21195481-21195714 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr9:21183391-21183669 | GM12878 | blood: | n/a | n/a |
3 | BATF | chr9:21214009-21214242 | GM12878 | blood: | n/a | n/a |
4 | BATF | chr9:21213980-21214258 | GM12878 | blood: | n/a | n/a |
5 | BATF | chr9:21183393-21183622 | GM12878 | blood: | n/a | n/a |
6 | BATF | chr9:21195452-21195727 | GM12878 | blood: | n/a | n/a |
7 | BCL11A | chr9:21183431-21183637 | GM12878 | blood: | n/a | chr9:21183522-21183531 |
8 | BCL11A | chr9:21213999-21214266 | GM12878 | blood: | n/a | chr9:21214111-21214120 |
9 | BCL11A | chr9:21195471-21195683 | GM12878 | blood: | n/a | chr9:21195583-21195592 |
10 | BCL11A | chr9:21213900-21214291 | GM12878 | blood: | n/a | chr9:21214111-21214120 |
11 | BCL11A | chr9:21195389-21195749 | GM12878 | blood: | n/a | chr9:21195583-21195592 |
12 | BHLHE40 | chr9:21195256-21195293 | GM12878 | blood: | n/a | n/a |
13 | CEBPB | chr9:21213807-21213921 | IMR90 | lung: | n/a | n/a |
14 | CEBPB | chr9:21183206-21183372 | A549 | lung: | n/a | n/a |
15 | CTCF | chr9:21195203-21195371 | MCF-7 | breast: | n/a | chr9:21195318-21195336 |
16 | CTCF | chr9:21195260-21195410 | GM12864 | blood: | n/a | chr9:21195318-21195336 |
17 | CTCF | chr9:21183040-21183190 | HCM | heart: | n/a | n/a |
18 | CTCF | chr9:21213680-21213830 | HAc | cerebellar: | n/a | n/a |
19 | CTCF | chr9:21213760-21213910 | GM12864 | blood: | n/a | n/a |
20 | CTCF | chr9:21195320-21195470 | MCF-7 | breast: | n/a | n/a |
21 | CTCF | chr9:21183200-21183350 | SK-N-SH_RA | brain: | n/a | chr9:21183259-21183277 |
22 | CTCF | chr9:21183142-21183363 | A549 | lung: | n/a | chr9:21183259-21183277 |
23 | CTCF | chr9:21211379-21211440 | Pancreas_OC | pancreas: | n/a | n/a |
24 | CTCF | chr9:21213760-21213910 | WERI-Rb-1 | eye: | n/a | n/a |
25 | CTCF | chr9:21182800-21182950 | NHLF | lung: | n/a | n/a |
26 | CTCF | chr9:21213757-21213940 | MCF-7 | breast: | n/a | n/a |
27 | CTCF | chr9:21195340-21195490 | HFF-Myc | foreskin: | n/a | n/a |
28 | CTCF | chr9:21185220-21185370 | HCFaa | heart: | n/a | n/a |
29 | CTCF | chr9:21195260-21195410 | AoAF | blood vessel: | n/a | chr9:21195318-21195336 |
30 | CTCF | chr9:21213660-21213810 | HVMF | connective: | n/a | n/a |
31 | CTCF | chr9:21213780-21213930 | BE2_C | brain: | n/a | n/a |
32 | CTCF | chr9:21201853-21201892 | LNCaP | prostate: | n/a | n/a |
33 | CTCF | chr9:21183114-21183386 | GM10266 | blood: | n/a | chr9:21183259-21183277 |
34 | CTCF | chr9:21213760-21213910 | AoAF | blood vessel: | n/a | n/a |
35 | CTCF | chr9:21183080-21183230 | HCM | heart: | n/a | n/a |
36 | CTCF | chr9:21195169-21195462 | LNCaP | prostate: | n/a | chr9:21195318-21195336 |
37 | CTCF | chr9:21213764-21213931 | GM10248 | blood: | n/a | n/a |
38 | CTCF | chr9:21213680-21213830 | NHLF | lung: | n/a | n/a |
39 | CTCF | chr9:21195260-21195410 | HCPEpiC | choroid plexus: | n/a | chr9:21195318-21195336 |
40 | CTCF | chr9:21227793-21227947 | GM10248 | blood: | n/a | n/a |
41 | CTCF | chr9:21195120-21195270 | HEEpiC | esophagus: | n/a | n/a |
42 | CTCF | chr9:21213660-21213810 | AG04450 | lung: | n/a | n/a |
43 | CTCF | chr9:21213880-21214030 | HCM | heart: | n/a | n/a |
44 | CTCF | chr9:21182880-21183030 | GM12872 | blood: | n/a | n/a |
45 | CTCF | chr9:21195195-21195415 | GM20000 | blood: | n/a | chr9:21195318-21195336 |
46 | CTCF | chr9:21213700-21213850 | GM12871 | blood: | n/a | n/a |
47 | CTCF | chr9:21187540-21187631 | Kidney_OC | kidney: | n/a | n/a |
48 | CTCF | chr9:21183200-21183350 | HEK293 | kidney: | n/a | chr9:21183259-21183277 |
49 | CTCF | chr9:21183118-21183375 | MCF-7 | breast: | n/a | chr9:21183259-21183277 |
50 | CTCF | chr9:21182883-21182997 | GM10266 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:21202213-21202263 | SKMC | muscle: | n/a |
2 | chr9:21187344-21187394 | GM19239 | blood: | n/a |
3 | chr9:21187344-21187394 | ECC-1 | luminal epithelium: | n/a |
4 | chr9:21202213-21202263 | HPAEpiC | pulmonary alveolar: | n/a |
5 | chr9:21187344-21187394 | HMEC | breast: | n/a |
6 | chr9:21187344-21187394 | SK-N-SH | brain: | n/a |
7 | chr9:21187344-21187394 | AG09319 | gingival: | n/a |
8 | chr9:21202213-21202263 | GM06990 | blood: | n/a |
9 | chr9:21202213-21202263 | NT2-D1 | testis: | n/a |
10 | chr9:21187344-21187394 | Jurkat | blood: | n/a |
11 | chr9:21202213-21202263 | HRCEpiC | kidney: | n/a |
12 | chr9:21187344-21187394 | HUVEC | blood vessel: | n/a |
13 | chr9:21202213-21202263 | NB4 | blood: | n/a |
14 | chr9:21187344-21187394 | LNCaP | prostate: | n/a |
15 | chr9:21202213-21202263 | HNPCEpiC | eye: | n/a |
16 | chr9:21187344-21187394 | AoSMC | blood vessel: | n/a |
17 | chr9:21187344-21187394 | PrEC | prostate: | n/a |
18 | chr9:21187344-21187394 | Caco-2 | colon: | n/a |
19 | chr9:21202213-21202263 | HCM | heart: | n/a |
20 | chr9:21187344-21187394 | NH-A | brain: | n/a |
21 | chr9:21187344-21187394 | MCF-7 | breast: | n/a |
22 | chr9:21202213-21202263 | ProgFib | skin: | n/a |
23 | chr9:21187344-21187394 | HCT-116 | colon: | n/a |
24 | chr9:21202213-21202263 | ECC-1 | luminal epithelium: | n/a |
25 | chr9:21187344-21187394 | HRPEpiC | eye: | n/a |
26 | chr9:21202213-21202263 | AG10803 | skin: | n/a |
27 | chr9:21202213-21202263 | HEK293 | kidney: | embryo |
28 | chr9:21202213-21202263 | AG09319 | gingival: | n/a |
29 | chr9:21202213-21202263 | HepG2 | liver: | n/a |
30 | chr9:21202213-21202263 | LNCaP | prostate: | n/a |
31 | chr9:21202213-21202263 | AoSMC | blood vessel: | n/a |
32 | chr9:21202213-21202263 | PFSK-1 | brain: | n/a |
33 | chr9:21187344-21187394 | AG10803 | skin: | n/a |
34 | chr9:21187344-21187394 | HCPEpiC | choroid plexus: | n/a |
35 | chr9:21202213-21202263 | IMR90 | lung: | fetal |
36 | chr9:21202213-21202263 | PrEC | prostate: | n/a |
37 | chr9:21202213-21202263 | BJ | skin: | n/a |
38 | chr9:21202213-21202263 | K562 | blood: | n/a |
39 | chr9:21187344-21187394 | PFSK-1 | brain: | n/a |
40 | chr9:21202213-21202263 | Hepatocyte | liver: | n/a |
41 | chr9:21187344-21187394 | A549 | lung: | n/a |
42 | chr9:21202213-21202263 | HCF | heart: | n/a |
43 | chr9:21202213-21202263 | HUVEC | blood vessel: | n/a |
44 | chr9:21187344-21187394 | NB4 | blood: | n/a |
45 | chr9:21187344-21187394 | BE2_C | brain: | n/a |
46 | chr9:21187344-21187394 | RPTEC | kidney: | n/a |
47 | chr9:21202213-21202263 | AG04450 | lung: | fetal |
48 | chr9:21187344-21187394 | GM12891 | blood: | n/a |
49 | chr9:21187344-21187394 | HEEpiC | esophagus: | n/a |
50 | chr9:21202213-21202263 | Hela-S3 | cervix: | n/a |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IFNA10-1 | chr9:21209188-21209778 | NONHSAT130374 |
2 | lnc-IFNA4-1 | chr9:21190653-21191243 | NONHSAT130373 |
No data |
No data |
Variant related genes | Relation type |
---|---|
IFNA7 | TF binding region |
IFNWP15 | TF binding region |
IFNWP9 | TF binding region |
IFNA17 | TF binding region |
IFNWP18 | TF binding region |
IFNA16 | TF binding region |
IFNA4 | TF binding region |
IFNA10 | TF binding region |
IFNA7 | CpG island |
IFNWP15 | CpG island |
IFNWP9 | CpG island |
IFNA17 | CpG island |
IFNWP18 | CpG island |
IFNA16 | CpG island |
IFNA4 | CpG island |
IFNA10 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186676038 | chr9:21181598-21181599 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs560154446 | chr9:21182825-21182826 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs529246091 | chr9:21182838-21182839 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs542917345 | chr9:21182843-21182844 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs562800578 | chr9:21182847-21182848 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs531800445 | chr9:21182848-21182849 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs372648991 | chr9:21182894-21182895 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs150176092 | chr9:21182901-21182902 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs533080396 | chr9:21182913-21182914 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs527417972 | chr9:21182928-21182929 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs546376952 | chr9:21182941-21182942 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs192186693 | chr9:21182977-21182978 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs7022016 | chr9:21182980-21182981 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs555718098 | chr9:21182984-21182985 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs569145569 | chr9:21182999-21183000 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs565385978 | chr9:21183032-21183033 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs10691782 | chr9:21183059-21183060 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs34336826 | chr9:21183060-21183061 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs397717153 | chr9:21183062-21183063 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs35389575 | chr9:21183063-21183064 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs537728295 | chr9:21183077-21183078 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs557967170 | chr9:21183095-21183096 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs577754382 | chr9:21183098-21183099 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs540767504 | chr9:21183100-21183101 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs553802207 | chr9:21183107-21183108 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs552032173 | chr9:21183141-21183142 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs113867718 | chr9:21183180-21183181 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs542577962 | chr9:21183197-21183198 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs28637304 | chr9:21183219-21183220 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs532057596 | chr9:21183225-21183226 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs545358726 | chr9:21183227-21183228 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs565512991 | chr9:21183228-21183229 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs148941898 | chr9:21183247-21183248 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs112312496 | chr9:21183284-21183285 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs111868548 | chr9:21183298-21183299 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs546729965 | chr9:21183310-21183311 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs528085697 | chr9:21183315-21183316 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs528920903 | chr9:21183346-21183347 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs12345537 | chr9:21183349-21183350 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs568855924 | chr9:21183356-21183357 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs145687518 | chr9:21183369-21183370 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs557762783 | chr9:21183395-21183396 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs571421305 | chr9:21183416-21183417 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs188655349 | chr9:21183431-21183432 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs138331261 | chr9:21183443-21183444 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs191902247 | chr9:21183444-21183445 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs542688515 | chr9:21183461-21183462 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs556170903 | chr9:21183462-21183463 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs7040257 | chr9:21183520-21183521 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs545689516 | chr9:21183525-21183526 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Glioblastoma multiforme | 21569311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Lung cancer | 21911935 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
head and neck squamous cell carcinoma | 21798897 | CNVD |
Cancer | 21253487 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Leukemia | 19602459 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Glioma | 20126413 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Melanoma | 17363583 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20581869 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
Oral cancer | 22144094 | CNVD |
Lung cancer | 21569311 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 19212409 | CNVD |
Epilepsy | 20502679 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:21182800-21184000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
2 | chr9:21183000-21183400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr9:21183000-21183400 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
4 | chr9:21183200-21184000 | Enhancers | Primary monocytes fromperipheralblood | blood |
5 | chr9:21183400-21184000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr9:21195200-21195600 | Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr9:21195200-21195800 | Active TSS | Hela-S3 | cervix |
8 | chr9:21195200-21196000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
9 | chr9:21195200-21196000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
10 | chr9:21195400-21195800 | Enhancers | Primary hematopoietic stem cells | blood |
11 | chr9:21195600-21195800 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr9:21195600-21196200 | Enhancers | GM12878-XiMat | blood |
13 | chr9:21195600-21196400 | Enhancers | Primary monocytes fromperipheralblood | blood |
14 | chr9:21195800-21196000 | Enhancers | Hela-S3 | cervix |
15 | chr9:21196200-21196600 | Weak transcription | GM12878-XiMat | blood |
16 | chr9:21196400-21197600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
17 | chr9:21196600-21197000 | Enhancers | GM12878-XiMat | blood |
18 | chr9:21198000-21198200 | Enhancers | Primary monocytes fromperipheralblood | blood |
19 | chr9:21198200-21198800 | Enhancers | Placenta | Placenta |
20 | chr9:21211400-21211800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
21 | chr9:21211400-21212200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
22 | chr9:21228000-21228400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |